The FDA advisory panel unanimously supported mRNA-1010/mFLUSIVA for adults 50–64 and 65+, and the stock is already reacting ...
Buy iShares 7-10 Year Treasury ETF (IEF) or, more directly, iShares 0-3 Month Treasury (SGOV) is too short; use IEF to ...
The stock sold off with the whole semis, but HSBC just lifted its server-CPU growth view (2026/27) and put a $200 target on ...
The weak jobs print pushed yields down and cut the odds of another Fed hike this year (75.6% vs ~84%). If the Fed delays ...
The stock is pulling back, but the new revenue-sharing program deepens customer lock-in beyond one-time GPU sales and turns ...
Deliveries beat hard (480k vs ~406–409k expected) and China/Shanghai momentum is accelerating (June Model 3/Y +24% YoY; Q2 ...
The news is a distraction (Trump praise + $250M “Trump Accounts” headline) while the real driver is the market’s rotation out ...
Q2 deliveries beat (12,194 vs ~11,000) and management immediately raised 2026 guidance to at least 65,000 from 62,000—this is ...
The new buyback + selective Bitcoin sales framework is designed to “buy time” until Bitcoin stabilizes, while strengthening ...
Bitget, the world's largest Universal Exchange (UEX), has launched US stock options, giving users direct access to trade ...
The $500M counter-UAS contract through 2029 plus record FY26 results (revenue +133%, EBITDA margin 22%, funded backlog $1.2B, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results